Devices, digital health, and the technology changing how care is delivered.
As air transportation for organs becomes more common, both in response to tech advancements and changing federal guidelines, the industry needs tools that synchronize communication between dispersed teams and can keep pace with air transport. The post Leveraging Technology to Navigate the New Era of Continuous Organ Distribution appeared first on MedCity News .
MMI built a robot to help surgeons perform microsurgical procedures with more control than is possible with the human hand alone.
InStride’s Series C round includes support from new investors Echo Health Ventures and FMZ Ventures, as well as existing investors .406 Ventures, Valtruis, General Catalyst and Mass General Brigham Ventures. The post InStride Raises $30M to Scale Pediatric Mental Health Support appeared first on MedCity News .
MultiValent Biotherapies is developing a peptide-like drug conjugate that hits two validated targets to treat prostate cancer. This clinical-stage asset was licensed from China-based Coherent Biopharma. The post New Cancer Biotech Unveils $27M for Dual-Targeting Prostate Cancer Drug appeared first on MedCity News .
The cardiac monitoring company said that a threat actor has demanded payment in exchange for not publicly releasing the stolen data.
The investment will add J&J’s manufacturing, packaging and distribution capabilities to meet growing demand for its contact lenses.
Reframing transportation as infrastructure, not a support service, means holding it to the same standard as any other component of care delivery. That requires these three things. The post Healthcare Access Depends on Infrastructure: Why Rural Communities Can’t Afford Fragmentation appeared first on MedCity News .
The autonomous healthcare system is about to take shape, and health systems must prepare to evolve alongside it. The post Natural Selection Will Weed Out the Weak in the Race to Autonomous Healthcare appeared first on MedCity News .
[Sponsored] The future of healthcare AI is not simply a technology conversation. It is a trust conversation. The post Healthcare AI Beyond the Buzzwords: Ambient, Generative, and Agentic Explained appeared first on MedCity News .
Elevance Health is leveraging AI for simplifying the member experience, improving the provider experience and making sure employees have the right information at the right time. The post Elevance Health’s 3 Key Priorities for AI appeared first on MedCity News .
Eli Lilly presented encouraging Phase 1 results for AJ1-11095 at the European Hematology Association (EHA) annual meeting in Stockholm. The drug, a type II JAK2 inhibitor in development for myelofibrosis, came from Lilly’s acquisition of biotech startup Ajax Therapeutics. The post Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med appeared first on MedCity News .
The Stelo over-the-counter glucose monitor can now be used by children as young as two years.
CEO Geoff Martha said the acquisition will enable “every neurovascular procedure to start with Medtronic.”
In the push toward a more seamless, digitally enabled future, it’s important we understand exactly how this rush to interoperability may actually harm patients, instead of helping, and what we can do to make sure they keep pace. The post Don’t Leave Healthcare’s Greatest Asset Behind on the Road to Interoperability appeared first on MedCity News .
Once data starts moving across multiple systems, it becomes hard to track unless you’ve been very intentional about it from the start. The post Where Healthcare Data Systems Fail and How to Build Them Better appeared first on MedCity News .
The Plausible Mechanism Framework is a breakthrough. Turning it into treatments that reach families will take five things the framework doesn’t provide. The post The FDA Opened the Door For Rare Disease Patients — Here’s What It Takes to Walk Through It appeared first on MedCity News .
The healthcare affordability crisis in the U.S. has become a trust crisis, with a growing share of Americans walking away from care altogether. Industry leaders say the fix requires something the system has never really done: starting with the patient. The post Why One in Four Americans Is Walking Away from Healthcare appeared first on MedCity News .
Why continuous audit readiness helps MedTech organizations move faster—without sacrificing confidence or control.
Paul Markovich, president and CEO of Ascendiun, shared his ideas for bringing down healthcare costs, including digital health records and changing how healthcare is paid for. The post Paul Markovich’s 4 Ideas to Reduce Healthcare Costs appeared first on MedCity News .
The industry needs a framework that can translate clinical nuance into a consistent, trusted representation across systems and use cases. The post In the Age of AI, Interoperability Isn’t Enough: Why Healthcare Needs Shared Understanding, Not Just Shared Data appeared first on MedCity News .
How America’s outdated insurance model is failing at its most important job The post The Myth of Insurance Networks appeared first on MedCity News .
The gap between how nicotine use has evolved and how cessation treatment has evolved is a meaningful part of why quit rates have plateaued. The post Smoking Cessation’s Quiet Design Failure appeared first on MedCity News .
The healthcare industry is spending more than ever on AI — but according to executives from Oracle Health, HCA Healthcare and BJC Health, much of that investment could be wasted. During a panel this week at HFMA’s annual conference, they argued that no amount of sophisticated tech can overcome a broken, antiquated data foundation. The post Bot vs. Bot: Why Healthcare AI Progress Might Be Stuck appeared first on MedCity News .
The U.S. Food and Drug Administration today cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM) for children, Dexcom Inc.’s Stelo Glucose Biosensor System, an integrated CGM (iCGM) indicated for people two years of age and older who do not use insulin.